Open AccessComparison of MANTA vs ProGlide Vascular Closure Device and 30-Day Outcomes in Transfemoral Transcatheter Aortic Valve Implantation
Author(s) -
Christos Eftychiou,
Nicolaos Eteocleous,
Andreas Mitsis,
Ioannis Zittis,
Kyriacos Papadopoulos,
Andria Petrou,
Maria Adamou,
Christos Kounnos,
Christos Bekos,
Panayiotis Avraamides
Publication year - 2022
Publication title -
texas heart institute journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.373
H-Index - 53
eISSN - 1526-6702
pISSN - 0730-2347
DOI - 10.14503/thij-21-7650
Subject(s) - medicine , mace , vascular closure device , cardiology , percutaneous , surgery , percutaneous coronary intervention , myocardial infarction
Vascular complications (VCs) after transfemoral transcatheter aortic valve implantation (TAVI) have an increased mortality risk, and vascular closure device (VCD) use is mandatory. The percutaneous MANTA VCD (Teleflex) is a novel collagen-based technology for closure of large-bore arteriotomies. We compared the MANTA VCD with the suture-based ProGlide VCD (Abbott Vascular).